Pharmacists in Tazewell, VA Accepting Medicare

4 Pharmacists found. Showing 1 - 4

Gizele Bowen, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 121 Ben Bolt Ave, Tazewell, VA 24651 Phone: 276-988-8758

Richard Lee Stansbury Jr. Jr., PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 160 Martingale Dr, Tazewell, VA 24651 Phone: 276-988-4871    Fax: 276-988-6966

Jasmine Dawn Clevinger Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 388 Ben Bolt Ave, Tazewell, VA 24651 Phone: 276-988-8850

Mr. David Vance, PHARMD. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 141 Ben Bolt Ave, Tazewell, VA 24651 Phone: 276-385-0584    Fax: 276-988-0517

News Archive

Progress on MDG targets is 'key priority' in 2010 for U.N. Secretary-General

U.N. Secretary-General Ban Ki-moon on Monday called 2010 "the year of development" and said "he would make the drive to achieve" the Millennium Development Goals (MDGs) by 2015 "one of his key priorities this year," Agence France-Presse/My Sinchew reports.

Study shows few adolescent females undergo pregnancy testing in hospital emergency department

Few adolescent females undergo pregnancy testing in the hospital emergency department, even when they complain of lower abdominal pain, or before they are exposed to radiation for tests or examinations, according to an abstract presented Friday, Oct. 19, at the American Academy of Pediatrics National Conference and Exhibition in New Orleans.

Study finds too low drug concentrations used for treatment of children with TB

The realization of medically treating different children uniquely may start with one of the deadliest diseases in existence: tuberculosis.

Positive data from AbbVie's HCV clinical development program presented at The Liver Meeting of AASLD

AbbVie, a global biopharmaceutical company, today announced data from the SURVEYOR studies of its investigational HCV regimen, ABT-493, an NS3/4A protease inhibitor, and ABT-530, an NS5A inhibitor, that show high rates of sustained virologic response at 12 weeks post-treatment (SVR 12) in non-cirrhotic patients with chronic hepatitis C virus (HCV) infection.

Read more Medical News

› Verified 2 days ago